about
Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice.Effect of sildenafil on the activity of some antidepressant drugs and electroconvulsive shock treatment in the forced swim test in miceAnticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice.Clavulanic acid does not affect convulsions in acute seizure tests in mice.Antidepressant-like activity of sildenafil following acute and subchronic treatment in the forced swim test in mice: effects of restraint stress and monoamine depletion.α-Spinasterol, a TRPV1 receptor antagonist, elevates the seizure threshold in three acute seizure tests in mice.Evaluation of the Anticonvulsant Effect of Brilliant Blue G, a Selective P2X7 Receptor Antagonist, in the iv PTZ-, Maximal Electroshock-, and 6 Hz-Induced Seizure Tests in MiceEvidences for pharmacokinetic interaction of riluzole and topiramate with pilocarpine in pilocarpine-induced seizures in rats.Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice.Effect of sildenafil, a selective phosphodiesterase 5 inhibitor, on the anticonvulsant action of some antiepileptic drugs in the mouse 6-Hz psychomotor seizure model.Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice.Sildenafil, a phosphodiesterase type 5 inhibitor, reduces antidepressant-like activity of paroxetine in the forced swim test in mice.Effect of quercetin and rutin in some acute seizure models in mice.Acute anticonvulsant effects of capric acid in seizure tests in mice.Sildenafil influences the anticonvulsant activity of vigabatrin and gabapentin in the timed pentylenetetrazole infusion test in mice.Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine.Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice.Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice.Role of the adenosine system and glucose restriction in the acute anticonvulsant effect of caprylic acid in the 6 Hz psychomotor seizure test in mice.NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in miceHBK-14 and HBK-15, triple 5-HT 1A , 5-HT 7 and 5-HT 3 antagonists with potent antidepressant- and anxiolytic-like properties, increase seizure threshold in various seizure tests in miceAnticonvulsant Activity of Pterostilbene in Zebrafish and Mouse Acute Seizure TestsMaximal electroshock induces changes in some markers of oxidative stress in miceOrphenadrine induces secondarily generalized convulsive status epilepticus in ratsEvaluation of the role of different neurotransmission systems in the anticonvulsant action of sildenafil in the 6 Hz-induced psychomotor seizure threshold test in miceAcute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studiesEffect of Pterostilbene, a Natural Analog of Resveratrol, on the Activity of some Antiepileptic Drugs in the Acute Seizure Tests in Mice
P50
Q36106513-80B9B3AB-3BDC-48D2-B6CB-EAA9FB98FADCQ37693900-05C73E47-8722-405C-AA4D-C9CB6BE6CA5BQ39888015-5CEC8DDC-C387-4AA6-A977-17F845F16950Q40135754-70DF6197-BC74-427A-8DDA-B5218E8E41C8Q40709156-F14469B9-2023-4D80-9F70-679DCAD28D93Q42046872-09DCE63D-CCAB-4345-B88B-792FBD2E321DQ42727469-7B29EB81-2421-4BE0-9702-6F7421F14745Q43218419-8C7C9670-37F2-452E-AA07-988BED252F5CQ44014551-E8C07D52-0B9A-4E8E-A7C6-42CDA8A6CE52Q46835634-DFF0C3AD-6B58-4C7D-A6B2-8B3DFA58C0BCQ47197710-B339654B-5D7A-4F31-A518-495462DE5E85Q48254496-8D9AF3A3-BB67-47DB-9941-F5E28B4B6D6EQ48288346-2856950F-0FF6-45F8-AB95-64D7F650767FQ48438676-72F14FCE-243E-44CE-8718-A3DA11871322Q48478480-39EE3D87-5CD1-4C66-8266-5F1378FE1126Q48730019-E56D2955-C8AF-466E-93F7-341AD644495EQ48735249-853ED3CD-72B3-497B-88BC-7EDA21A4DC1FQ50443779-0869557E-4AA0-4F1E-89A3-8E30823DF71AQ51311783-EB949CA3-4910-4A0C-BEB4-A5137192AF3DQ60473690-9F328FFC-1C07-423A-89E0-3249002A85A5Q63382951-8050FAF9-FAD8-438B-9408-82089085A8EDQ64234729-C2ABB657-05C2-442D-B281-5B4736D32ADAQ80867339-CEDAF990-73D7-4A89-910A-AC10294AE754Q83311905-E2E42F11-AC2B-44F3-99F7-48307A3BD9B4Q91771685-1ED8372F-7A68-4809-AA6E-6339262043B2Q92386219-1D6F6AC5-4077-4959-9221-873771E47728Q92406210-9326DD31-0844-43DE-8968-85E33E5D144D
P50
description
researcher ORCID ID = 0000-0002-9446-7343
@en
name
Dorota Nieoczym
@ast
Dorota Nieoczym
@en
Dorota Nieoczym
@es
Dorota Nieoczym
@nl
Dorota Nieoczym
@pl
type
label
Dorota Nieoczym
@ast
Dorota Nieoczym
@en
Dorota Nieoczym
@es
Dorota Nieoczym
@nl
Dorota Nieoczym
@pl
altLabel
Dorota Teresa Nieoczym
@pl
prefLabel
Dorota Nieoczym
@ast
Dorota Nieoczym
@en
Dorota Nieoczym
@es
Dorota Nieoczym
@nl
Dorota Nieoczym
@pl
P1153
15062974600
P31
P3124
P496
0000-0002-9446-7343